<![CDATA[Scala Biodesign]]>https://www.scala-bio.com/success-storiesRSS for NodeTue, 25 Aug 2026 23:50:47 GMT<![CDATA[Stabilizing the malaria vaccine protein]]>https://www.scala-bio.com/post/copy-of-stabilizing-the-malaria-vaccine-protein68c968a95a84d94edbe1bf7fSun, 02 Nov 2025 14:53:12 GMTgilishklar<![CDATA[Design of a challenging drug target]]>https://www.scala-bio.com/post/design-of-a-challenging-drug-target68e3a6a168fa888a144142baSat, 01 Nov 2025 12:37:32 GMTgilishklar<![CDATA[Stabilizing glucocerebrosidase (GCase) for Gaucher disease gene therapy]]>https://www.scala-bio.com/post/stabilizing-glucocerebrosidase-for-gaucher-disease-gene-therapy68d3eda2b43801901d450c4dFri, 31 Oct 2025 14:28:51 GMTgilishklar<![CDATA[Simultaneous optimization of antibody developability & humanness]]>https://www.scala-bio.com/post/simultaneous-optimization-of-antibody-developability-humanness68e3aaa23af439b9bda2cbf4Thu, 30 Oct 2025 13:11:29 GMTgilishklar<![CDATA[Improving catalytic activity and selectivity]]>https://www.scala-bio.com/post/improving-catalytic-activity-and-selectivity68d3faac9a52887193bb3c95Wed, 29 Oct 2025 10:14:24 GMTgilishklar<![CDATA[Co-optimizing stability and activity in a DNA processing enzyme]]>https://www.scala-bio.com/post/co-optimizing-stability-and-activity-in-a-dna-processing-enzyme68e3b4154a2f8583aa9a96d1Tue, 28 Oct 2025 13:28:14 GMTgilishklar<![CDATA[Designing enzymes with complementary enantioselectivity profiles]]>https://www.scala-bio.com/post/enantioselectivity-use-case68e3b6373af439b9bda2e53aMon, 27 Oct 2025 13:34:12 GMTgilishklar<![CDATA[Enabling microbial production of a human enzyme]]>https://www.scala-bio.com/post/enabling-microbial-production-of-a-human-enzyme68e3b20f2849e99ade0d6ae1Sat, 25 Oct 2025 21:00:00 GMTgilishklar